Literature DB >> 3763726

Vascularized periosteal grafts: an experimental study using two different forms of tibial periosteum in rabbits.

T Takato, K Harii, T Nakatsuka, K Ueda, T Ootake.   

Abstract

Three groups of rabbits were studied to investigate the osteogenic capacity of vascularized periosteum. It was found that such tissue, especially in the form of musculoperiosteal flaps, produced a significant amount of bone. It is concluded that vascularized periosteal flaps have an excellent osteogenic capacity even though they are not subjected to weight or stress.

Entities:  

Mesh：

Year:  1986        PMID： 3763726     DOI： 10.1097/00006534-198610000-00010

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN： 0032-1052            Impact factor:   4.730


  5 in total

1.  The Vascularized Medial Femoral Corticoperiosteal Flap for Reconstruction of Bony Defects within the Upper and Lower Extremities.

Authors:  Karim Bakri; Alexander Y Shin; Steven L Moran
Journal:  Semin Plast Surg       Date:  2008-08       Impact factor: 2.314

2.  The reverse flow medial knee osteoperiosteal flap for skeletal reconstruction of the leg. Description and anatomical basis.

Authors:  R Hertel; A C Masquelet
Journal:  Surg Radiol Anat       Date:  1989       Impact factor: 1.246

3.  Periosteal flaps: anatomical bases of sites of elevation.

Authors:  C V Penteado; A C Masquelet; M C Romana; J P Chevrel
Journal:  Surg Radiol Anat       Date:  1990       Impact factor: 1.246

Review 4.  The corticoperiosteal medial femoral supracondylar flap: anatomical study for clinical evaluation in mandibular osteoradionecrosis.

Authors:  Guillaume Dubois; Raphael Lopez; Prasanna Puwanarajah; Leslie Noyelles; Frederic Lauwers
Journal:  Surg Radiol Anat       Date:  2010-04-07       Impact factor: 1.246

5.  Periosteal preservation: a new technique in resection of bone high-grade malignant tumors in children-about eleven cases.

Authors:  Mahmoud Smida; Ameni Ammar; Faten Fedhila; Wiem Douira; Samia Sassi
Journal:  World J Surg Oncol       Date:  2022-09-26       Impact factor: 3.253
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.